Endotoxemia: Clinical Trials

1 trial for Endotoxemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Endotoxemia: new trials by email Literature Review of Endotoxemia trials Research Report on Endotoxemia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia - VECTOR II
C1-esterase inhibitor, Endotoxin - Innate Immune Response, Endotoxemia
Phase 3CompletedRadboud University Medical Center202013-09-012014-12-02

Narrower conditions

Inflammation (1)  ·  Sepsis (1)

Broader conditions

Bacteremia (1)  ·  Infections (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Systemic Inflammatory Response Syndrome (1)  ·  Toxemia (1)

Interventions

Complement C1 Inhibitor Protein (1)  ·  Endotoxins (1)  ·  let-363 protein, C elegans (1)

Sponsors

Radboud University Medical Center (1)

Countries

Netherlands (1)

Top investigators

Hans Hoeven, Prof (1)

Results publications

PMID 28515092